These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 6125451)
1. [Role of renin profile and age in the choice of the therapeutic approach of arterial hypertension (author's transl)]. Glorioso N; Madeddu P; Dessì Fulgheri P; Sanna G; Fiori C; Dettori S; Cocco F; Rappelli A G Ital Cardiol; 1981; 11(12):2117-25. PubMed ID: 6125451 [TBL] [Abstract][Full Text] [Related]
2. The place of the calcium antagonist verapamil in antihypertensive therapy. Bühler FR; Hulthén UL; Kiowski W; Müller FB; Bolli P J Cardiovasc Pharmacol; 1982; 4 Suppl 3():S350-7. PubMed ID: 6184567 [TBL] [Abstract][Full Text] [Related]
3. [The role of renin after betablocking diuretic and vasodilator treatment in essential hypertension (author's transl)]. Lombardo M; Fusco M; Valente D G Ital Cardiol; 1979; 9(12):1363-70. PubMed ID: 45015 [TBL] [Abstract][Full Text] [Related]
4. [Correlations between blood pressure, blood volume and plasma renin during therapy with diuretics in essential hypertension. Comparison between the mineralocorticoid antagonist spironolactone and the "loop" diuretic mefruside]. Beretta-Piccoli C; Weidmann P; de Châtel R; Hirsch D; Reubi FC Schweiz Med Wochenschr; 1977 Jan; 107(4):104-15. PubMed ID: 834983 [TBL] [Abstract][Full Text] [Related]
5. [Cardiovascular response to isometric exercise test during beta blocker and diuretic treatment in essential arterial hypertension]. Maiorano G; Contursi V; Saracino E; Ricapito M; Di Lecce G Clin Ter; 1988 Mar; 124(6):443-50. PubMed ID: 2904846 [No Abstract] [Full Text] [Related]
6. [Long-term therapy with beta receptor blockaders]. Bühler FR Z Gesamte Inn Med; 1981 Mar; 36(6):283-8 suppl. PubMed ID: 6114598 [TBL] [Abstract][Full Text] [Related]
7. Approach to drug therapy for hypertension. Kuchel OG; Mahon WA; McKenzie JK; Ogilvie RI Can Med Assoc J; 1979 Mar; 120(5):565-70. PubMed ID: 35278 [TBL] [Abstract][Full Text] [Related]
8. [The renin-angiotensin-aldosterone system in hypertensive subjects. III- The use of beta-blockers in reno-vascular hypertension (author's transl)]. Lardoux H; Vial FS; Ménard J; Corvol P; Milliez P Nouv Presse Med; 1977 Sep; 6(30):2659-63. PubMed ID: 20602 [TBL] [Abstract][Full Text] [Related]
9. The effects of antihypertensive combination therapy on lipid and glucose metabolism: hydrochlorothiazide plus sotalol vs. hydrochlorothiazide plus captopril. Middeke M; Richter WO; Schwandt P; Holzgreve H Int J Clin Pharmacol Ther; 1997 Jun; 35(6):231-4. PubMed ID: 9208337 [TBL] [Abstract][Full Text] [Related]
10. Antihypertensive therapy with diuretics and beta-blockers at fixed dosage: comparison between the combinations labetalol plus chlorthalidone and atenolol plus chlorthalidone. Roja M; Cumetti C; Vergani A; Montanari C; De Cristofaro A Drugs Exp Clin Res; 1985; 11(12):851-60. PubMed ID: 2873012 [TBL] [Abstract][Full Text] [Related]
11. Considerations on physiopathological approaches to the treatment of hypertension. Zanchetti A; Leonetti G; Morganti A; Terzoli L Clin Exp Pharmacol Physiol Suppl; 1978; 4():1-9. PubMed ID: 28189 [TBL] [Abstract][Full Text] [Related]
12. [Effectiveness of treatment with beta-blocking agents and diuretics in fixed combination, in aged hypertensive patients]. Paciaroni E; Quattrini L; Saccomanno G; Andreoni A G Ital Cardiol; 1980; 10(12):1737-41. PubMed ID: 6114010 [TBL] [Abstract][Full Text] [Related]
13. Beta-adrenergic blockade in diuretic-treated patients with essential hypertension. Bravo EL; Tarazi RC; Dustan HP N Engl J Med; 1975 Jan; 292(2):66-70. PubMed ID: 234005 [TBL] [Abstract][Full Text] [Related]
14. [Plasma renin activity in essential hypertension: different short- und long-term effects of diuretics (author's transl)]. Esch I; Placheta P; Gaul G Wien Klin Wochenschr; 1976 Jun; 88(13):415-8. PubMed ID: 824860 [TBL] [Abstract][Full Text] [Related]
15. [Renin-angiotensin-aldosterone system in the treatment of essential hypertension with a beta-adrenergic blocker: sotalol]. Psadas C; Sánchez G; Zaldívar HM; Rangel J; Cuéllar A; Serrano PA Arch Inst Cardiol Mex; 1977; 47(2):160-70. PubMed ID: 901052 [TBL] [Abstract][Full Text] [Related]
16. Calcium antagonists, firstline partners for betablockers in hypertension. Bühler FR Z Kardiol; 1984; 73 Suppl 2():95-9. PubMed ID: 6152093 [TBL] [Abstract][Full Text] [Related]
17. Prazosin in hypertension. Part I. Clinical experience in 100 patients. Turner AS; Watson OF; Brocklehurst JE N Z Med J; 1977 Sep; 86(596):282-5. PubMed ID: 24193 [TBL] [Abstract][Full Text] [Related]
18. Diabetes and hypertension, the deadly duet: importance, therapeutic strategy, and selection of drug therapy. Deedwania PC Cardiol Clin; 2005 May; 23(2):139-52. PubMed ID: 15694743 [TBL] [Abstract][Full Text] [Related]
19. Prazosin in general practice. Musgrove JP N Z Med J; 1981 Mar; 93(679):156-8. PubMed ID: 6112725 [TBL] [Abstract][Full Text] [Related]
20. [Measurement of plasma renin activity, blood volume and exchangeable sodium: an aid in the orientation of treatment of essential arterial hypertension]. Olmer M; Ducros J; Grandvuillemin M; Salvadori JM Sem Hop; 1977 May; 53(20):1147-53. PubMed ID: 20666 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]